Botulinum Toxin: Does it have a Place in the Management of Depression? Matthew V. Rudorfer Editorial 01 March 2018 Pages: 97 - 100
Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose Adeleke D. AdewumiSamantha A. HollingworthRosa Alati Systematic Review 01 March 2018 Pages: 101 - 116
Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment Claudio SolaroGiulia GamberiniFabio Giuseppe Masuccio Review Article 07 February 2018 Pages: 117 - 133
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies Katharina StegmayerSebastian WaltherPeter van Harten Review Article 09 February 2018 Pages: 135 - 147
Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease Michele A. Faulkner Review Article 26 February 2018 Pages: 149 - 159
An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis Caila VaughnAisha BushraBianca Weinstock-Guttman Review Article 05 March 2018 Pages: 161 - 178
Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial Jayashri KulkarniNatalie ThomasCaroline Gurvich Original Research Article 16 March 2018 Pages: 179 - 187